Policy Indications: Safe gaming – new guidelines to support children online  |  Policy Indications: EUniWell selected as a 'European University'  |  Health Monitor: Covid-19 Lockdown May Lead to Cabin Fever  |  Education Information: Students launch lockdown travel guide for UK tourists  |  Leadership Instincts: Professor Nicholas Stern awarded 2020 SIEPR Prize  |  Leadership Instincts: LSE becomes the eighth full member of CIVICA  |  Education Information: Emerging trends in Higher Education examined  |  International Edu News: Delirium, rare brain inflammation and stroke linked to Covid-19  |  International Edu News: Euclid space telescope’s camera a step closer to imaging galaxies  |  International Edu News: Anna Strongman appointed new CEO of Oxford University Development  |  National Edu News: PM dedicates Rewa Ultra Mega Solar Power project to the nation  |  Policy Indications: New Working Norms  |  Leadership Instincts: IIT’s Face Mask Gives a Boost to Textile Industry  |  Leadership Instincts: Imperial College Supplies Backpack Activity Kits  |  Teacher Insights: No Additional Fees for Online Learning  |  
May 28, 2020 Thursday 06:38:20 PM IST

Science and Technology in finding solutions to combat COVID-19

National Edu News

At a media briefing here today, Dr. Vinod Paul, Member NITI Aayog and Professor K. Vijay Raghavan, Principal Scientific Adviser to the Government of India, summarised activities on COVID-19 related to Science and Technology in the areas of vaccines, drug discovery, diagnostics and testing.

On vaccines, it was pointed out that the process is usually slow and fraught with uncertainties. But, in order to succeed against COVID-19 a large number of parallel efforts are needed. This is being done globally and nationally. Indian academia and start-ups are working on vaccine candidates in the very strong Indian vaccine industry. There are three kinds of attempts being made. The first are indigenous efforts. The second are globally collaborative efforts where Indian organisations are taking a lead role and the third is Indian participation in global efforts. With such a large portfolio, followed by efforts at risk- mitigation for manufacturing and stockpiling, success is better assured.

On drug discovery, our scientific efforts take three approaches. The first is the repurposing of extant drugs to see how effective they are against the virus and in mitigating the consequences of the disease. Second, Phyto-pharmaceuticals and extracts from medicinal plants are being tested. Finally, using a variety of approaches, new drug discovery including a ‘Hackathon’ for computational drug discovery is being undertaken.

A conglomeration of research efforts have resulted in new tests and testing kits. These include new tests for detection of the virus and also for antibody detection. The latter are being used for serological studies,


The speed of these developments is made possible by the collaborative efforts of our scientists, institutions and science agencies. The regulatory system has also been closely engaged, combining speed with quality.


Comments